Unknown OBSERVATIONAL NCT04405869

Thromboembolic Events in Severe COVID-19 Patients (COVICLOT)

Incidence of Thromboembolic Events and Prognosis of COVID-19 Patients Hospitalized in Intensive Care Units in France

Sponsor: University Hospital, Strasbourg, France

Updated 5 times since 2020 Last updated: May 27, 2020 Started: Apr 29, 2020 Primary completion: Apr 30, 2021 Completion: Apr 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Pulmonary Thromboembolism and is currently ongoing. University Hospital, Strasbourg, France leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jun 2022 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jan 2021 — Jun 2022 [monthly]

Recruiting
Jun 2020 — Jan 2021 [monthly]

Recruiting

First recorded

Apr 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Strasbourg, France

Data source: University Hospital, Strasbourg, France

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Strasbourg, France